• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重症患者新发房颤发病率的高灵敏度估计

High-Sensitivity Estimate of the Incidence of New-Onset Atrial Fibrillation in Critically Ill Patients.

作者信息

McIntyre William F, Belley-Côté Emilie P, Vadakken Maria E, Rai Anand S, Lengyel Alexandra P, Rochwerg Bram, Bhatnagar Akash K, Deif Bishoy, Um Kevin J, Spence Jessica, Connolly Stuart J, Bangdiwala Shrikant I, Rao-Melacini Purnima, Healey Jeff S, Whitlock Richard P

机构信息

Population Health Research Institute, McMaster University, Hamilton, ON, Canada.

Department of Medicine, McMaster University, Hamilton, ON, Canada.

出版信息

Crit Care Explor. 2021 Jan 8;3(1):e0311. doi: 10.1097/CCE.0000000000000311. eCollection 2021 Jan.

DOI:10.1097/CCE.0000000000000311
PMID:33458680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7803666/
Abstract

UNLABELLED

To estimate the incidence of new-onset atrial fibrillation in critically ill patients.

DESIGN

Prospective cohort.

SETTING

Medical-surgical ICU.

SUBJECTS

Consecutive patients without a history of atrial fibrillation but with atrial fibrillation risk factors.

INTERVENTIONS

Electrocardiogram patch monitor until discharge from hospital or up to 14 days.

MEASUREMENTS AND MAIN RESULTS

A total of 249 participants (median age of 71 yr [interquartile range] 64-78 yr; 35% female) completed the study protocol of which 158 (64%) were admitted to ICU for medical illness, 78 (31%) following noncardiac surgery, and 13 (5%) with trauma. Median Acute Physiology and Chronic Health Evaluation II score was 16 (interquartile range, 12-22). Median duration of patch electrocardiogram monitoring, ICU, and hospital lengths of stay were 6 (interquartile range, 3-12), 4 (interquartile range, 2-8), and 11 days (interquartile range, 5-23 d), respectively.Atrial fibrillation ≥ 30 seconds was detected by the patch in 44 participants (17.7%), and three participants (1.2%) had atrial fibrillation detected clinically after patch removal, resulting in an overall atrial fibrillation incidence of 18.9% (95% CI, 14.2-24.3%).Total duration of atrial fibrillation ranged from 53 seconds to the entire monitoring time. The proportion of participants with ≥1 episode(s) of ≥6 minute, ≥1 hour, ≥12 hour and ≥24 hour duration was 14.8%, 13.2%, 7.0%, and 5.3%, respectively. The clinical team recognized only 70% of atrial fibrillation cases that were detected by the electrocardiogram patch.

CONCLUSIONS

Among patients admitted to an ICU, the incidence of new-onset atrial fibrillation is approximately one in five, although approximately one-third of cases are not recognized by the clinical team.

摘要

未标注

评估危重症患者新发房颤的发生率。

设计

前瞻性队列研究。

地点

内科-外科重症监护病房。

研究对象

无房颤病史但有房颤危险因素的连续患者。

干预措施

使用心电图贴片监测直至出院或最长14天。

测量指标及主要结果

共有249名参与者(年龄中位数71岁[四分位间距]64 - 78岁;35%为女性)完成研究方案,其中158名(64%)因内科疾病入住重症监护病房,78名(31%)接受非心脏手术后入住,13名(5%)因创伤入住。急性生理与慢性健康状况评价II评分中位数为16(四分位间距,12 - 22)。贴片心电图监测的中位数时长、重症监护病房住院时长及住院总时长分别为6天(四分位间距,3 - 12天)、4天(四分位间距,2 - 8天)和11天(四分位间距,5 - 23天)。贴片检测到44名参与者(17.7%)出现持续≥30秒的房颤,3名参与者(1.2%)在移除贴片后临床检测到房颤,总体房颤发生率为18.9%(95%可信区间,14.2 - 24.3%)。房颤总时长从53秒至整个监测时间不等。持续时间≥6分钟、≥1小时、≥12小时及≥24小时的发作次数≥1次的参与者比例分别为14.8%、13.2%、7.0%和5.3%。临床团队仅识别出心电图贴片检测到的房颤病例中的70%。

结论

在入住重症监护病房的患者中,新发房颤的发生率约为五分之一,尽管约三分之一的病例未被临床团队识别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09aa/7803666/80b3be645288/cc9-3-e0311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09aa/7803666/80b3be645288/cc9-3-e0311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09aa/7803666/80b3be645288/cc9-3-e0311-g001.jpg

相似文献

1
High-Sensitivity Estimate of the Incidence of New-Onset Atrial Fibrillation in Critically Ill Patients.危重症患者新发房颤发病率的高灵敏度估计
Crit Care Explor. 2021 Jan 8;3(1):e0311. doi: 10.1097/CCE.0000000000000311. eCollection 2021 Jan.
2
New-Onset Atrial Fibrillation in the Critically Ill.危重症患者新发房颤
Crit Care Med. 2017 May;45(5):790-797. doi: 10.1097/CCM.0000000000002325.
3
Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness : A Matched Cohort Study.非心脏手术或内科疾病住院期间检出的短暂新发心房颤动患者心房颤动复发:一项配对队列研究。
Ann Intern Med. 2023 Oct;176(10):1299-1307. doi: 10.7326/M23-1411. Epub 2023 Oct 3.
4
Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.ICU 患者新发心房颤动的药物和非药物治疗及结局:CAFE 范围综述和数据库分析。
Health Technol Assess. 2021 Nov;25(71):1-174. doi: 10.3310/hta25710.
5
Diagnostic Value of a Wearable Continuous Electrocardiogram Monitoring Device (AT-Patch) for New-Onset Atrial Fibrillation in High-Risk Patients: Prospective Cohort Study.可穿戴式连续心电图监测设备(AT-Patch)对高危患者新发心房颤动的诊断价值:前瞻性队列研究。
J Med Internet Res. 2023 Sep 18;25:e45760. doi: 10.2196/45760.
6
Clinical and Genetic Contributors to New-Onset Atrial Fibrillation in Critically Ill Adults.危重症成人新发心房颤动的临床和遗传因素。
Crit Care Med. 2020 Jan;48(1):22-30. doi: 10.1097/CCM.0000000000004034.
7
Hydroxyethyl starch for fluid resuscitation in critically ill patients.羟乙基淀粉在危重症患者液体复苏中的应用。
Can J Anaesth. 2013 Jul;60(7):709-13. doi: 10.1007/s12630-013-9936-4. Epub 2013 Apr 20.
8
Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) incidence study.应激性短暂性心房颤动(AFOTS)发病率研究的设计与原理
J Electrocardiol. 2019 Nov-Dec;57:95-99. doi: 10.1016/j.jelectrocard.2019.09.014. Epub 2019 Sep 6.
9
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.新冠肺炎危重症患者新发心房颤动的发生率及临床转归:一项多中心队列研究——新发心房颤动与 COVID-19。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231156178. doi: 10.1177/10760296231156178.
10
Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial.心脏手术后住院期间连续心电图监测对未诊断心房颤动检出率的影响:一项随机临床试验。
JAMA Netw Open. 2021 Aug 2;4(8):e2121867. doi: 10.1001/jamanetworkopen.2021.21867.

引用本文的文献

1
Atrial fibrillation in critical illness: state of the art.危重症中的心房颤动:最新进展
Intensive Care Med. 2025 May 5. doi: 10.1007/s00134-025-07895-0.
2
Research priorities for the study of atrial fibrillation during acute and critical illness: recommendations from the Symposium on Atrial Fibrillation in Acute and Critical Care.急性和危重症期间心房颤动研究的优先事项:急性和危重症护理中心房颤动研讨会的建议
BMC Proc. 2024 Nov 5;18(Suppl 22):23. doi: 10.1186/s12919-024-00309-x.
3
Peri-mortem arrhythmias in the non-cardiac intensive care unit.

本文引用的文献

1
Detection of Previously Unrecognized (Subclinical) Atrial Fibrillation.检测先前未被识别(亚临床)的心房颤动。
Am J Cardiol. 2020 Jul 15;127:169-175. doi: 10.1016/j.amjcard.2020.04.013. Epub 2020 Apr 23.
2
Initial Precipitants and Recurrence of Atrial Fibrillation.初始诱发因素与心房颤动的复发。
Circ Arrhythm Electrophysiol. 2020 Mar;13(3):e007716. doi: 10.1161/CIRCEP.119.007716. Epub 2020 Feb 12.
3
New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study.
非心脏重症监护病房中的濒死心律失常
Nurs Crit Care. 2025 Mar;30(2):e13097. doi: 10.1111/nicc.13097. Epub 2024 Jun 3.
4
Magnesium prophylaxis of new-onset atrial fibrillation: A systematic review and meta-analysis.镁预防新发心房颤动:系统评价和荟萃分析。
PLoS One. 2023 Oct 26;18(10):e0292974. doi: 10.1371/journal.pone.0292974. eCollection 2023.
5
Differences in Postoperative Atrial Fibrillation Incidence and Outcomes After Cardiac Surgery According to Assessment Method and Definition: A Systematic Review and Meta-Analysis.根据评估方法和定义,心脏手术后心房颤动发生率和结局的差异:系统评价和荟萃分析。
J Am Heart Assoc. 2023 Oct 3;12(19):e030907. doi: 10.1161/JAHA.123.030907. Epub 2023 Sep 30.
6
[Atrial fibrillation on the intensive care unit : The special prognostic importance of the first manifestation].[重症监护病房中的心房颤动:首次发作的特殊预后重要性]
Herzschrittmacherther Elektrophysiol. 2022 Dec;33(4):391-397. doi: 10.1007/s00399-022-00899-z. Epub 2022 Sep 26.
7
COVID-19 and AF: What About the Long Game?新冠病毒与房颤:长期情况如何?
JACC Clin Electrophysiol. 2021 Sep;7(9):1196-1197. doi: 10.1016/j.jacep.2021.05.018.
新发心房颤动与危重症成年患者相关结局及资源利用:一项多中心回顾性队列研究。
Crit Care. 2020 Jan 13;24(1):15. doi: 10.1186/s13054-020-2730-0.
4
Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) incidence study.应激性短暂性心房颤动(AFOTS)发病率研究的设计与原理
J Electrocardiol. 2019 Nov-Dec;57:95-99. doi: 10.1016/j.jelectrocard.2019.09.014. Epub 2019 Sep 6.
5
New-onset atrial fibrillation in adult critically ill patients: a scoping review.成人危重症患者新发心房颤动:范围综述。
Intensive Care Med. 2019 Jul;45(7):928-938. doi: 10.1007/s00134-019-05633-x. Epub 2019 May 14.
6
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的聚焦更新:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
J Am Coll Cardiol. 2019 Jul 9;74(1):104-132. doi: 10.1016/j.jacc.2019.01.011. Epub 2019 Jan 28.
7
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.2018 年加拿大心血管学会心房颤动管理指南重点更新。
Can J Cardiol. 2018 Nov;34(11):1371-1392. doi: 10.1016/j.cjca.2018.08.026.
8
Atrial fibrillation detected initially during acute medical illness: A systematic review.急性疾病期间首次检测到的心房颤动:系统评价。
Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):130-141. doi: 10.1177/2048872618799748. Epub 2018 Nov 7.
9
Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) follow-up cohort study.应激性短暂性房颤(AFOTS)随访队列研究的设计与原理
Clin Cardiol. 2018 Oct;41(10):1273-1280. doi: 10.1002/clc.23053. Epub 2018 Oct 18.
10
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.血管加压素联合儿茶酚胺类血管加压药与儿茶酚胺类药物单独用于分布性休克患者心房颤动的比较:系统评价和荟萃分析。
JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528.